Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
PLoS Pathog
; 17(12): e1010022, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34855916
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunization, Secondary
/
Antibodies, Neutralizing
/
SARS-CoV-2
/
COVID-19
/
Vaccine Efficacy
/
BNT162 Vaccine
/
Antibodies, Viral
Limits:
Humans
Language:
En
Journal:
PLoS Pathog
Year:
2021
Type:
Article
Affiliation country:
United kingdom